FOXO4-DRI Prices
Also known as Proxofim; FOXO4 D-Retro-Inverso
17 listings from 12 vendors, normalised to one honest price per milligram.
Cheapest per mg
$11.25/mg
At
Peptide Crafters
Vendors
12
Sizes
2mg, 5mg, 10mg, 10mg Kit (10 vials), 12mg, 15mg
Disclosure. Some vendors below are Peptul partners and pay us a commission when you buy through our link. Rows here are ordered by price per milligram only - paying us never moves a vendor up. Current discount codes are shown on the full price board.
FOXO4-DRI price per mg by vendor
Prices last collected August 19, 2026.
| Vendor | Size | Price | Per mg | |
|---|---|---|---|---|
| Peptide CraftersVerified COAShips US | 12mg | $135.00 | $11.25 | View |
| VPeptide CanadaVerified COA | 10mg Kit (10 vials) | $1441.55 | $14.42 | View |
| Paramount PeptidesVerified COAShips US | 15mg | $255.00 | $17.00 | View |
| Umbrella LabsVerified COAShips US | 5mg | $89.99 | $18.00 | View |
| VPeptide CanadaVerified COA | 10mg | $180.19 | $18.02 | View |
| Pharma Lab Global CanadaVerified COA | 10mg | $200.51 | $20.05 | View |
| Verified PeptidesVerified COAShips US | 10mg | $220.00 | $22.00 | View |
| Umbrella LabsVerified COAShips US | 2mg | $44.99 | $22.50 | View |
| Huaian Hanyou PeptideVerified COA | 10mg | $225.00 | $22.50 | View |
| Cocer PeptidesVerified COAShips US | 10mg | $235.00 | $23.50 | View |
| Umbrella LabsVerified COAShips US | 10mg | $249.99 | $25.00 | View |
| Biotech PeptidesVerified COAShips US | 10mg | $270.00 | $27.00 | View |
| BioLongevity LabsPeptul partnerVerified COAShips US | 10mg | $274.97 | $27.50 | View |
| Raw AminoVerified COAShips US | 10mg | $276.00 | $27.60 | View |
| Behemoth LabzVerified COAShips US | 10mg | $342.40 | $34.24 | View |
About FOXO4-DRI
- What it is
- FOXO4-DRI is a synthetic D-retro-inverso cell-penetrating peptide designed to act as a senolytic. It disrupts the interaction between the FOXO4 protein and the tumor suppressor p53, which triggers programmed cell death selectively in senescent cells. In cell and rodent studies it has been reported to clear senescent cells and improve some markers of aging. It has not been tested in human clinical trials.
- How it works
- It disrupts the FOXO4 and p53 interaction, releasing p53 to trigger apoptosis selectively in senescent cells.
- Researched for
- Senescent cell clearance; longevity research; age-related disease
- Half-life
- Not established in humans
- Familiarity
- Advanced
- Research evidence
- Animal studies only
- Regulatory status
- Phase 3
- Key risk
- None documented
For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.